These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 26930381)

  • 1. Ionizing Radiation Exposure and Basal Cell Carcinoma Pathogenesis.
    Li C; Athar M
    Radiat Res; 2016 Mar; 185(3):217-28. PubMed ID: 26930381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genomic instability in the epidermis induced by atomic bomb (A-bomb) radiation: a long-lasting health effect in A-bomb survivors.
    Naruke Y; Nakashima M; Suzuki K; Kondo H; Hayashi T; Soda M; Sekine I
    Cancer; 2009 Aug; 115(16):3782-90. PubMed ID: 19517458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Small Molecule Inhibitors of the Hedgehog Pathway in the Treatment of Basal Cell Carcinoma of the Skin.
    Danhof R; Lewis K; Brown M
    Am J Clin Dermatol; 2018 Apr; 19(2):195-207. PubMed ID: 28887802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitochondrial D310 D-Loop instability and histological subtypes in radiation-induced cutaneous basal cell carcinomas.
    Boaventura P; Pereira D; Mendes A; Batista R; da Silva AF; Guimarães I; Honavar M; Teixeira-Gomes J; Lopes JM; Máximo V; Soares P
    J Dermatol Sci; 2014 Jan; 73(1):31-9. PubMed ID: 24091058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Basal cell carcinoma: pathophysiology.
    Sehgal VN; Chatterjee K; Pandhi D; Khurana A
    Skinmed; 2014; 12(3):176-81. PubMed ID: 25134314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Locally advanced and metastatic basal cell carcinoma: molecular pathways, treatment options and new targeted therapies.
    Ruiz Salas V; Alegre M; Garcés JR; Puig L
    Expert Rev Anticancer Ther; 2014 Jun; 14(6):741-9. PubMed ID: 24611655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of Primary Cilia Drives Switching from Hedgehog to Ras/MAPK Pathway in Resistant Basal Cell Carcinoma.
    Kuonen F; Huskey NE; Shankar G; Jaju P; Whitson RJ; Rieger KE; Atwood SX; Sarin KY; Oro AE
    J Invest Dermatol; 2019 Jul; 139(7):1439-1448. PubMed ID: 30707899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vismodegib: an inhibitor of the Hedgehog signaling pathway in the treatment of basal cell carcinoma.
    Proctor AE; Thompson LA; O'Bryant CL
    Ann Pharmacother; 2014 Jan; 48(1):99-106. PubMed ID: 24259609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Basal cell carcinoma: a paradigm for targeted therapies.
    Dreier J; Felderer L; Barysch M; Rozati S; Dummer R
    Expert Opin Pharmacother; 2013 Jul; 14(10):1307-18. PubMed ID: 23656611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Basal cell carcinoma pathogenesis and therapy involving hedgehog signaling and beyond.
    Bakshi A; Chaudhary SC; Rana M; Elmets CA; Athar M
    Mol Carcinog; 2017 Dec; 56(12):2543-2557. PubMed ID: 28574612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vismodegib: a hedgehog pathway inhibitor for locally advanced and metastatic basal cell carcinomas.
    Sobanko JF; Okman J; Miller C
    J Drugs Dermatol; 2013 Oct; 12(10 Suppl):s154-5. PubMed ID: 24085062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiotherapy-induced basal cell carcinomas of the scalp: are they genetically different?
    Tessone A; Amariglio N; Weissman O; Jacob-Hirsch J; Liran A; Stavrou D; Haik J; Orenstein A; Winkler E
    Aesthetic Plast Surg; 2012 Dec; 36(6):1387-92. PubMed ID: 23052377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current landscape for treatment of advanced basal cell carcinoma.
    Foley P
    Australas J Dermatol; 2015 Mar; 56 Suppl 1():1-7. PubMed ID: 25715811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular basis of basal cell carcinogenesis in the atomic-bomb survivor population: p53 and PTCH gene alterations.
    Mizuno T; Tokuoka S; Kishikawa M; Nakashima E; Mabuchi K; Iwamoto KS
    Carcinogenesis; 2006 Nov; 27(11):2286-94. PubMed ID: 16777989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances in the treatment of Basal cell carcinoma: Hedgehog inhibitors.
    Kudchadkar R; Lewis K; Gonzalez R
    Semin Oncol; 2012 Apr; 39(2):139-44. PubMed ID: 22484185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vismodegib for radiation-induced multiple basal cell carcinomas (BCCs) of the scalp.
    Tauber G; Pavlovsky L; Fenig E; Hodak E
    J Am Acad Dermatol; 2015 Nov; 73(5):799-801. PubMed ID: 26320385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identifying patients at risk for recurrent or advanced BCC.
    Hamid O; Goldenberg G
    J Drugs Dermatol; 2013 Nov; 12(11):1246-52; quiz 1253-4. PubMed ID: 24196332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A cell identity switch allows residual BCC to survive Hedgehog pathway inhibition.
    Biehs B; Dijkgraaf GJP; Piskol R; Alicke B; Boumahdi S; Peale F; Gould SE; de Sauvage FJ
    Nature; 2018 Oct; 562(7727):429-433. PubMed ID: 30297801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting the hedgehog pathway to treat basal cell carcinoma.
    Geeraert P; Williams JS; Brownell I
    J Drugs Dermatol; 2013 May; 12(5):519-23. PubMed ID: 23652945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vismodegib.
    Meiss F; Zeiser R
    Recent Results Cancer Res; 2014; 201():405-17. PubMed ID: 24756807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.